Numerous clinical trials investigate chloroquine across diverse therapeutic indications, including infectious diseases such as malaria and SARS-CoV-2, as well as inflammatory and autoimmune disorders like pulmonary sarcoidosis and primary Sjögren's syndrome. Spanning Phase 1 through Phase 4 trials alongside observational protocols, these studies encompass completed, active, and upcoming recruitments. Research initiatives are sponsored by diverse entities, including academic medical centers, public hospital networks, and pharmaceutical companies.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06652113 | RECRUITING | Recurrent Pregnancy Loss; Euthyroid With Thyroid Antibodies |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-11-15 | |
| NCT07750067 | RECRUITING | Melanoma Metastatic; NRAS Mutation |
Sun Yat-sen University |
2026-04-01 | PHASE2 |
| NCT05842174 | RECRUITING | Hepatocellular Carcinoma |
VA Office of Research and Development |
2026-04-01 | PHASE1; PHASE2 |
| NCT05841758 | RECRUITING | Sarcoidosis, Pulmonary |
Hospices Civils de Lyon |
2024-07-30 | PHASE4 |
| NCT07061717 | NOT_YET_RECRUITING | Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2025-07-01 | PHASE3 |
| NCT06408298 | RECRUITING | Resectable Localized Prostate Cancer |
Lionel.D.Lewis, MD |
2026-01-06 | EARLY_PHASE1 |
| NCT05799378 | RECRUITING | Systemic Lupus Erythematosus |
NYU Langone Health |
2024-06-27 | PHASE3 |
| NCT07675291 | NOT_YET_RECRUITING | Lupus Nephritis |
Nanfang Hospital, Southern Medical University |
2026-06 | |
| NCT07430592 | NOT_YET_RECRUITING | Malaria; Malaria Vivax; Radical Cure |
R. Kiplin Guy |
2026-10-01 | PHASE2 |
| NCT07533136 | NOT_YET_RECRUITING | Uncomplicated P. Vivax Mono-infection |
Walter Reed Army Institute of Research (WRAIR) |
2026-05-01 | |
| NCT07557927 | NOT_YET_RECRUITING | Discoid Lupus Erythematosus |
Kunming Pharmaceuticals, Inc. |
2026-04-30 | PHASE2 |
| NCT04381936 | RECRUITING | Pneumonia |
University of Oxford |
2020-03-19 | PHASE3 |
| NCT06971744 | RECRUITING | Ovarian Cancer |
Medical University of South Carolina |
2025-12-18 | PHASE2 |
| NCT03414502 | RECRUITING | Rheumatoid Arthritis |
University of Nebraska |
2007-12-10 | PHASE3 |
| NCT05733000 | RECRUITING | Advanced Biliary Tract Carcinoma; Advanced Colorectal Carcinoma; Advanced Gastroesophageal Junction Adenocarcinoma; Advanced Lung Adenocarcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Urothelial Carcinoma; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Metastatic Biliary Tract Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Metastatic Lung Adenocarcinoma; Metastatic Ovarian Carcinoma; Metastatic Pancreatic Carcinoma; Metastatic Urothelial Carcinoma; Refractory Biliary Tract Carcinoma; Refractory Colorectal Carcinoma; Refractory Gastroesophageal Junction Adenocarcinoma; Refractory Lung Adenocarcinoma; Refractory Ovarian Carcinoma; Refractory Pancreatic Carcinoma; Refractory Urothelial Carcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage III Lung Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8 |
Northwestern University |
2023-03-08 | PHASE2 |
| NCT07138898 | RECRUITING | Rheumatic Disease |
NYU Langone Health |
2025-12-12 | PHASE2 |
| NCT06350630 | RECRUITING | IgA Nephropathy |
Centre Hospitalier Universitaire de Saint Etienne |
2025-06-26 | PHASE2 |
| NCT07230028 | NOT_YET_RECRUITING | Lyme Borreliosis, Nervous System |
Radboud University Medical Center |
2027-03-01 | PHASE4 |
| NCT07343635 | RECRUITING | Erythematotelangiectatic Rosacea |
The Fourth Affiliated Hospital of Zhejiang University School of Medicine |
2026-02-01 | |
| NCT04911816 | RECRUITING | Adenocarcinoma of the Pancreas |
West Virginia University |
2021-07-16 | PHASE1; PHASE2 |
| NCT03598595 | ACTIVE_NOT_RECRUITING | Recurrent Osteosarcoma; Refractory Osteosarcoma |
M.D. Anderson Cancer Center |
2019-01-28 | PHASE1; PHASE2 |
| NCT05036226 | RECRUITING | Prostate Cancer Recurrent; Solid Tumor, Adult |
Medical University of South Carolina |
2022-03-03 | PHASE1; PHASE2 |
| NCT04316169 | WITHDRAWN | Solid Tumor; Advanced Breast Cancer |
Medical College of Wisconsin |
2021-10-21 | PHASE1 |
| NCT05041907 | RECRUITING | COVID-19 |
University of Oxford |
2021-09-30 | PHASE2 |
| NCT05287321 | RECRUITING | Preeclampsia |
Yoo-min Kim |
2022-05-31 | PHASE3 |
| NCT06862284 | NOT_YET_RECRUITING | Primary Sjögren's Syndrome (pSS) |
Peking University People's Hospital |
2025-03-10 | PHASE2 |
| NCT05843188 | ACTIVE_NOT_RECRUITING | Metastatic Colorectal Cancer |
University Health Network, Toronto |
2023-08-09 | PHASE2 |
| NCT04532346 | RECRUITING | Interstitial Lung Disease; Surfactant Dysfunction |
Children's Hospital of Fudan University |
2024-09-01 | EARLY_PHASE1 |
| NCT06816810 | NOT_YET_RECRUITING | Parkinson&Amp;#39;s Disease |
Ottawa Hospital Research Institute |
2025-03 | PHASE2 |
| NCT04464759 | ACTIVE_NOT_RECRUITING | Melanoma |
Ravi Amaravadi, MD |
2020-10-21 | PHASE1; PHASE2 |
| NCT06319560 | RECRUITING | Diabetes in Pregnancy; Type 2 Diabetes |
National University of Malaysia |
2024-03-24 | |
| NCT06768294 | NOT_YET_RECRUITING | Calcium Pyrophosphate Deposition Disease; Chondrocalcinosis |
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
2025-01 | PHASE2 |
| NCT06467526 | NOT_YET_RECRUITING | Sudden Hearing Loss |
Chang Gung Memorial Hospital |
2024-07-01 | PHASE2 |
| NCT06666491 | RECRUITING | Malaria, Vivax |
GlaxoSmithKline |
2024-11-13 | PHASE3 |
| NCT04201457 | ACTIVE_NOT_RECRUITING | Low Grade Glioma (LGG) of Brain With BRAF Aberration; High Grade Glioma (HGG) of the Brain With BRAF Aberration; Low Grade Glioma of Brain With Neurofibromatosis Type 1 |
Pediatric Brain Tumor Consortium |
2020-01-17 | PHASE1; PHASE2 |
| NCT04132505 | COMPLETED | Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8 |
M.D. Anderson Cancer Center |
2019-10-22 | PHASE1 |
| NCT05518110 | TERMINATED | Pancreatic Cancer |
Cancer Trials Ireland |
2023-05-31 | PHASE2 |
| NCT06328387 | UNKNOWN | Advanced Breast Cancer; Metastatic Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-01-29 | PHASE1; PHASE2 |
| NCT02735707 | RECRUITING | Community-acquired Pneumonia, Influenza, COVID-19 |
UMC Utrecht |
2016-04-11 | PHASE3 |
| NCT06479304 | RECRUITING | Immune Thrombocytopenia With Positive ANA Antibodies |
Yunfeng Cheng |
2024-04-24 | |
| NCT06479291 | RECRUITING | Immune Thrombocytopenia With Positive ANA Antibodies |
Yunfeng Cheng |
2024-07 | |
| NCT06479317 | RECRUITING | Immune Thrombocytopenia With Positive ANA Antibodies |
Yunfeng Cheng |
2024-04-24 | |
| NCT05083780 | ACTIVE_NOT_RECRUITING | Pancreatic Cancer |
Changhoon Yoo |
2021-11-30 | PHASE1 |
| NCT06076837 | TERMINATED | Pancreatic Cancer Metastatic; Pancreatic Adenocarcinoma Metastatic |
HonorHealth Research Institute |
2025-01-09 | PHASE1 |
| NCT05365893 | ACTIVE_NOT_RECRUITING | Pancreatic Ductal Adenocarcinoma |
Fox Chase Cancer Center |
2021-10-20 | EARLY_PHASE1 |
| NCT03165136 | UNKNOWN | Recurrent Miscarriage; First Trimester Abortion |
University Hospital, Brest |
2017-12-04 | PHASE3 |
| NCT05126147 | RECRUITING | Graves Ophthalmopathy |
National Taiwan University Hospital |
2022-03-21 | PHASE4 |
| NCT06776445 | COMPLETED | Rosacea; Rosacea Subtype 1 (Erythematotelangiectatic) |
First Affiliated Hospital of Chongqing Medical University |
2024-01-05 | PHASE1 |
| NCT06083688 | COMPLETED | Malaria,Falciparum; Anemia in Children |
Liverpool School of Tropical Medicine |
2024-10-14 | PHASE4 |
| NCT05626348 | RECRUITING | Arthritis, Rheumatoid |
Qilu Hospital of Shandong University |
2021-12-22 | PHASE4 |
| NCT05119140 | ACTIVE_NOT_RECRUITING | Ulcerative Colitis (Disorder) |
Icahn School of Medicine at Mount Sinai |
2022-06-10 | PHASE1; PHASE2 |
| NCT05113004 | RECRUITING | Primary Sjögren's Syndrome (pSS) |
Assistance Publique - Hôpitaux de Paris |
2022-01-20 | PHASE2 |
| NCT03825289 | TERMINATED | Metastatic Pancreatic Carcinoma; Stage II Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer; Unresectable Pancreatic Carcinoma |
University of Utah |
2019-01-30 | PHASE1 |
| NCT07753967 | COMPLETED | Malaria Vivax |
Jimma University |
2024-12-01 | |
| NCT04981145 | RECRUITING | Primary Sjögren's Syndrome |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2022-01-14 | PHASE4 |
| NCT05737680 | UNKNOWN | Pericarditis Idiopathic Recurrent |
Hippocration General Hospital |
2023-02 | PHASE3 |
| NCT04787991 | COMPLETED | Metastatic Pancreatic Adenocarcinoma |
Cancer Insight, LLC |
2021-08-09 | PHASE1 |
| NCT05942911 | TERMINATED | Rheumatoid Arthritis |
Incannex Healthcare Ltd |
2023-11-22 | PHASE2 |
| NCT05443178 | UNKNOWN | Tuberculosis Infection |
University of Zurich |
2022-01-04 | PHASE1 |
| NCT04275778 | WITHDRAWN | Antiphospholipid Syndrome in Pregnancy; Anticoagulants |
Assistance Publique - Hôpitaux de Paris |
2021-07-09 | PHASE2 |
| NCT05961202 | RECRUITING | Inflammatory Cardiomyopathy; Myocarditis |
Tongji Hospital |
2021-11-01 | PHASE2; PHASE3 |
| NCT05016297 | COMPLETED | Sjogren's Syndrome |
Peking Union Medical College Hospital |
2022-07-14 | PHASE2 |
| NCT04120883 | TERMINATED | Retinitis Pigmentosa |
University of Michigan |
2020-02-25 | PHASE1; PHASE2 |
| NCT03030118 | COMPLETED | Systemic Lupus Erythematosus |
Milton S. Hershey Medical Center |
2017-12-28 | PHASE2 |
| NCT05666336 | UNKNOWN | Systemic Lupus Erythematosus |
Fen Li |
2022-12-31 | PHASE4 |
| NCT04397679 | TERMINATED | Glioblastoma; Gliosarcoma |
Barbara Ann Karmanos Cancer Institute |
2021-08-12 | PHASE1 |
| NCT05221320 | TERMINATED | Tumor, Solid; Gastrointestinal Cancer |
BioMed Valley Discoveries, Inc |
2022-05-26 | PHASE2 |
| NCT04873895 | TERMINATED | Colorectal Neoplasms Malignant |
Abramson Cancer Center at Penn Medicine |
2022-01-24 | PHASE1 |
| NCT03774472 | COMPLETED | Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8 |
M.D. Anderson Cancer Center |
2018-08-20 | PHASE1; PHASE2 |
| NCT05972551 | Recruiting | Osteogenesis Imperfecta |
Amgen |
2024-04-22 | Phase 3 |
| NCT05890573 | Recruiting | Pulmonary Fibrosis|COVID-19 Pneumonia |
Second Affiliated Hospital School of Medicine Zhejiang University |
2024-04-16 | Not Applicable |
| NCT05841758 | Not yet recruiting | Sarcoidosis Pulmonary |
Hospices Civils de Lyon |
2024-04-01 | Phase 4 |
| NCT04011410 | COMPLETED | Prostate Cancer Recurrent |
Patrick Hensley |
2019-12-03 | PHASE2 |
| NCT03994874 | Not yet recruiting | Congestive Heart Failure |
Iperboreal Pharma Srl |
2024-03 | Phase 1|Phase 2 |
| NCT06117722 | Not yet recruiting | Chronic Heart Failure |
Elpen Pharmaceutical Co. Inc. |
2024-03-01 | -- |
| NCT03503058 | COMPLETED | Malaria |
Sanaria Inc. |
2022-05-07 | PHASE2 |
| NCT04669197 | COMPLETED | Untreated Resectable Pancreatic Adenocarcinoma; Borderline Resectable Pancreatic Adenocarcinoma; Locally Advanced Pancreatic Adenocarcinoma |
HonorHealth Research Institute |
2020-12-01 | PHASE2 |
| NCT04527549 | TERMINATED | Clinical Stage IV Cutaneous Melanoma AJCC v8; Locally Advanced Melanoma; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Unresectable Melanoma |
ECOG-ACRIN Cancer Research Group |
2021-06-01 | PHASE2 |
| NCT05084872 | UNKNOWN | Mastocytosis |
University Hospital, Toulouse |
2021-10 | PHASE2; PHASE3 |
| NCT06432101 | COMPLETED | Primary Sjögren's Syndrome |
Senyue Zhang |
2023-01-01 | |
| NCT05678335 | UNKNOWN | Sjogren Syndrome With Other Organ Involvement |
Peking Union Medical College Hospital |
2023-02 | PHASE2; PHASE3 |
| NCT02432417 | WITHDRAWN | Glioblastoma; Astrocytoma, Grade IV |
Maastricht Radiation Oncology |
2023-11-10 | PHASE2 |
| NCT05013463 | UNKNOWN | Multiple Sclerosis, Secondary Progressive |
University of Calgary |
2021-10-01 | PHASE2 |
| NCT03513211 | COMPLETED | Prostate Cancer |
St Vincent's Hospital, Sydney |
2018-08-23 | PHASE1; PHASE2 |
| NCT04386057 | COMPLETED | Pancreatic Cancer; Advanced Cancer |
Kimberly Perez, MD |
2020-05-27 | PHASE2 |
| NCT05980156 | COMPLETED | Malaria,Falciparum; Anemia in Children |
University of Maryland, Baltimore |
2023-02-13 | PHASE4 |
| NCT02466581 | UNKNOWN | Rheumatoid Arthritis |
Karolinska Institutet |
2015-02-03 | PHASE4 |
| NCT00813423 | COMPLETED | Adult Solid Neoplasm |
National Cancer Institute (NCI) |
2010-02-19 | PHASE1 |
| NCT04524702 | COMPLETED | Advanced Pancreatic Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8 |
Emory University |
2020-09-14 | PHASE2 |
| NCT03025087 | TERMINATED | Individuals Undergoing Cardiac and General Surgery |
Duke University |
2017-06-19 | PHASE4 |
| NCT04372082 | WITHDRAWN | Sars-CoV2 |
University Hospital, Lille |
2020-05 | PHASE3 |
| NCT06044805 | COMPLETED | Efficacy; Malaria; Chloroquine; Vivax Malaria |
Dinka Dugassa |
2022-12-19 | PHASE4 |
| NCT04228263 | COMPLETED | Unexplained Recurrent Miscarriage |
Assiut University |
2020-01-01 | |
| NCT05247554 | UNKNOWN | Pulmonary Sarcoidosis |
Assistance Publique - Hôpitaux de Paris |
2022-03-01 | PHASE3 |
| NCT03813771 | UNKNOWN | Rheumatoid Arthritis |
University of Leeds |
2019-03 | PHASE4 |
| NCT03979651 | COMPLETED | Metastatic NRAS Melanoma |
Hospices Civils de Lyon |
2019-10-15 | |
| NCT03529396 | COMPLETED | Vivax Malaria; G6PD Deficiency |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2018-07-20 | PHASE2 |
| NCT02026232 | TERMINATED | Type 2 Diabetes Mellitus |
Washington University School of Medicine |
2012-03 | |
| NCT04569890 | UNKNOWN | Rheumatoid Arthritis; Pregnancy Related |
RenJi Hospital |
2020-12-01 | |
| NCT02603146 | TERMINATED | Healthy Participants; Rheumatoid Arthritis (RA) Prevention |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-04-27 | PHASE2 |
| NCT05237843 | UNKNOWN | Recurrent Pregnancy Loss |
Ain Shams University |
2022-03-01 | PHASE1 |
| NCT03428945 | TERMINATED | Type1 Diabetes Mellitus |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2018-08-15 | PHASE2 |
| NCT03929211 | WITHDRAWN | Myelodysplastic Syndromes; Progressive Disease |
Wake Forest University Health Sciences |
2021-05 | PHASE1; PHASE2 |
| NCT05244954 | COMPLETED | Malaria,Falciparum; Anemia in Children |
University of Maryland, Baltimore |
2022-02-01 | PHASE4 |
| NCT03377179 | COMPLETED | Cholangiocarcinoma; Cholangiocarcinoma Non-resectable; Cholangiocarcinoma, Perihilar; Cholangiocarcinoma, Extrahepatic; Cholangiocarcinoma, Intrahepatic |
RedHill Biopharma Limited |
2018-03-07 | PHASE2 |
| NCT04438837 | UNKNOWN | Coronavirus Disease 2019 (COVID-19); Post-Exposure Prophylaxis |
Rambam Health Care Campus |
2020-07 | |
| NCT04335084 | COMPLETED | COVID-19; Coronavirus Infection; Sars-CoV2; Corona Virus Infection; COVID; Coronavirus; Coronavirus-19; Coronavirus 19 |
ProgenaBiome |
2020-06-22 | PHASE2 |
| NCT03032406 | ACTIVE_NOT_RECRUITING | Breast Cancer Stage IIB |
Abramson Cancer Center at Penn Medicine |
2017-01-23 | PHASE2 |
| NCT04566133 | TERMINATED | Bile Duct Cancer; Biliary Cancer; Biliary Tract Neoplasms; Cholangiocarcinoma |
National Cancer Institute (NCI) |
2022-02-15 | PHASE2 |
| NCT04573153 | TERMINATED | COVID-19 |
ScandiBio Therapeutics AB |
2020-09-21 | PHASE2; PHASE3 |
| NCT04214418 | TERMINATED | Gastrointestinal Cancer |
Columbia University |
2020-02-12 | PHASE1; PHASE2 |
| NCT04359953 | TERMINATED | COVID-19 Infection |
University Hospital, Strasbourg, France |
2020-04-25 | PHASE3 |
| NCT04341207 | UNKNOWN | Cancer & COVID 19 |
Gustave Roussy, Cancer Campus, Grand Paris |
2020-04-03 | PHASE2 |
| NCT04303507 | COMPLETED | COVID19; Coronavirus; Acute Respiratory Illnesses |
University of Oxford |
2020-04-29 | |
| NCT04390152 | TERMINATED | Acute Respiratory Distress Syndrome |
BioXcellerator |
2020-01-13 | PHASE1; PHASE2 |
| NCT01506973 | COMPLETED | Advanced Adenocarcinoma; Metastatic Adenocarcinoma |
Abramson Cancer Center at Penn Medicine |
2011-12 | PHASE1; PHASE2 |
| NCT03305263 | UNKNOWN | Recurrent Pregnancy Loss |
Rigshospitalet, Denmark |
2018-01-25 | PHASE3 |
| NCT04163107 | COMPLETED | Multiple Myeloma |
Norwegian University of Science and Technology |
2020-01-07 | PHASE1 |
| NCT03754179 | UNKNOWN | Melanoma |
Universitair Ziekenhuis Brussel |
2018-01-23 | PHASE1; PHASE2 |
| NCT05311813 | COMPLETED | COVID-19 Pandemic |
Beni-Suef University |
2021-06-01 | |
| NCT04590274 | WITHDRAWN | Covid19; SARS (Severe Acute Respiratory Syndrome) |
International Brain Research Foundation |
2020-11 | PHASE1 |
| NCT04338906 | WITHDRAWN | COVID |
Heinrich-Heine University, Duesseldorf |
2020-05 | PHASE4 |
| NCT04624269 | UNKNOWN | Antiphospholipid Syndrome; Recurrent Miscarriage |
Shanghai First Maternity and Infant Hospital |
2020-12-01 | PHASE4 |
| NCT04342169 | COMPLETED | Coronavirus Infection; Coronavirus; Infectious Disease |
University of Utah |
2020-04-04 | PHASE2 |
| NCT02257424 | COMPLETED | Advanced BRAF Mutant Melanoma |
Abramson Cancer Center at Penn Medicine |
2014-10 | PHASE1; PHASE2 |
| NCT04954040 | UNKNOWN | Acute Respiratory Distress Syndrome; Covid19 |
Maimónides Biomedical Research Institute of Córdoba |
2021-02-10 | PHASE2 |
| NCT04363827 | TERMINATED | COVID19; Hydroxychloroquine; Prophylaxis; Treatment; SARS-CoV-2 |
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
2020-05-14 | PHASE2 |
| NCT04380818 | UNKNOWN | Pneumonia, Viral |
Grupo de Investigación Clínica en Oncología Radioterapia |
2020-06-05 | |
| NCT03671174 | UNKNOWN | Undifferentiated Connective Tissue Disease; Recurrent Pregnancy Loss |
RenJi Hospital |
2019-08-02 | |
| NCT04437693 | UNKNOWN | COVID 19 |
Hamad Medical Corporation |
2020-08-31 | PHASE2; PHASE3 |
| NCT04303299 | COMPLETED | SARS-COV-2 Infections; COVID-19 |
Department of Medical Services Ministry of Public Health of Thailand |
2020-08-19 | PHASE3 |
| NCT05026801 | WITHDRAWN | Respiratory Tract Infection Viral |
Iterum Therapeutics, International Limited |
2021-02-08 | PHASE3 |
| NCT04964583 | UNKNOWN | Covid19 |
Coordinación de Investigación en Salud, Mexico |
2021-01-20 | PHASE2; PHASE3 |
| NCT04389359 | WITHDRAWN | COVID-19 |
Cambridge University Hospitals NHS Foundation Trust |
2020-09 | PHASE2; PHASE3 |
| NCT04466540 | COMPLETED | COVID-19 |
Hospital Alemão Oswaldo Cruz |
2020-05-12 | PHASE4 |
| NCT01573754 | COMPLETED | Porphyria Cutanea Tarda |
The University of Texas Medical Branch, Galveston |
2006-03-21 | PHASE2 |
| NCT03208907 | COMPLETED | Malaria, Vivax; Therapeutics |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2018-07-05 | PHASE3 |
| NCT04459702 | WITHDRAWN | COVID; COVID-19; Corona Virus Infection; Coronavirus Infection; Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere; Coronavirus-19; SARS-CoV 2; SARS Pneumonia |
ProgenaBiome |
2020-07 | PHASE2 |
| NCT04372017 | TERMINATED | COVID-19; SARS-CoV 2 |
Sanford Health |
2020-05-14 | PHASE3 |
| NCT02913157 | COMPLETED | Multiple Sclerosis, Primary Progressive |
University of Calgary |
2016-11 | PHASE2 |
| NCT04371926 | WITHDRAWN | COVID-19 |
Texas Cardiac Arrhythmia Research Foundation |
2020-06 | |
| NCT04715295 | UNKNOWN | COVID-19 |
Yaounde Central Hospital |
2020-10-05 | PHASE4 |
| NCT04360759 | WITHDRAWN | Covid-19; HIV |
University of Cape Town |
2020-05-01 | PHASE3 |
| NCT04334967 | SUSPENDED | COVID-19; Corona Virus Infection; SARS-CoV-2; 2019-nCoV; 2019 Novel Coronavirus |
Providence Health & Services |
2020-03-30 | PHASE4 |
| NCT04373044 | TERMINATED | Symptomatic COVID-19 Infection Laboratory-Confirmed |
University of Southern California |
2020-05-01 | PHASE2 |
| NCT02374021 | COMPLETED | Arthritis, Rheumatoid |
Brigham and Women's Hospital |
2016-07 | PHASE4 |
| NCT04364815 | WITHDRAWN | COVID-19 |
University of the Philippines |
2020-12 | PHASE3 |
| NCT04381988 | TERMINATED | COVID-19; Cancer |
Memorial Sloan Kettering Cancer Center |
2020-05-07 | PHASE2 |
| NCT04344444 | TERMINATED | COVID-19 |
LCMC Health |
2020-04-13 | PHASE3 |
| NCT04341727 | TERMINATED | Coronavirus Infection |
Washington University School of Medicine |
2020-04-04 | PHASE3 |
| NCT04369742 | TERMINATED | COVID-19 |
NYU Langone Health |
2020-04-15 | PHASE2 |
| NCT04363450 | UNKNOWN | COVID-19; Corona Virus Infection; Wuhan Coronavirus; Prophylaxis; Healthcare Worker; Sars-CoV2; Hydroxychloroquine |
Louisiana State University Health Sciences Center in New Orleans |
2020-04-27 | PHASE3 |
| NCT04318444 | TERMINATED | COVID-19; Corona Virus Infection |
Columbia University |
2020-03-29 | PHASE2; PHASE3 |
| NCT04374942 | TERMINATED | Pre-Exposure Prophylaxis; Coronavirus; SARS-CoV 2 |
Megan Landes |
2020-04-30 | PHASE3 |
| NCT04712279 | UNKNOWN | Covid19 |
Corpometria Institute |
2021-01-25 | PHASE2; PHASE3 |
| NCT02722369 | TERMINATED | Small Cell Lung Cancer |
University College, London |
2017-03-14 | PHASE2 |
| NCT04363866 | WITHDRAWN | COVID-19; SARS-CoV-2 |
Oregon Health and Science University |
2020-08 | PHASE2 |
| NCT04363203 | SUSPENDED | SARS-CoV-2; COVID-19 |
Salomeh Keyhani MD |
2020-04-30 | PHASE3 |
| NCT04342221 | TERMINATED | COVID-19, Hydroxychloroquine Sulfate |
University Hospital Tuebingen |
2020-03-29 | PHASE3 |
| NCT04334928 | COMPLETED | Coronavirus Infection |
Plan Nacional sobre el Sida (PNS) |
2020-04-15 | PHASE3 |
| NCT04349371 | TERMINATED | COVID; Coronavirus Infection |
Columbia University |
2020-04-21 | PHASE2 |
| NCT01266057 | COMPLETED | Advanced Cancers |
M.D. Anderson Cancer Center |
2011-04-28 | PHASE1 |
| NCT04860284 | UNKNOWN | Covid19 |
Makerere University |
2020-09-18 | PHASE2 |
| NCT04345861 | TERMINATED | Coronavirus Infection; Pneumonia, Viral |
University Hospital, Montpellier |
2020-04-11 | PHASE2; PHASE3 |
| NCT04322396 | TERMINATED | Virus Diseases; Infection Viral; Corona Virus Infection |
Chronic Obstructive Pulmonary Disease Trial Network, Denmark |
2020-04-06 | PHASE2 |
| NCT04403100 | UNKNOWN | COVID-19; Coronavirus Infection; Virus Disease; Acute Respiratory Infection; SARS-CoV Infection |
Cardresearch |
2020-06-03 | PHASE3 |
| NCT04981379 | COMPLETED | Covid19 |
Health Institutes of Turkey |
2020-11-16 | PHASE3 |
| NCT04746365 | COMPLETED | Covid19 |
Elaraby Hospital |
2020-12-06 | PHASE4 |
| NCT04605588 | TERMINATED | SARS-CoV Infection; Covid19 |
Rutgers, The State University of New Jersey |
2020-12-02 | PHASE2 |
| NCT04597775 | UNKNOWN | SARS-CoV Infection |
Regional Center for Disease Control and Prevention, Jordan |
2020-10-27 | PHASE2; PHASE3 |
| NCT04334382 | UNKNOWN | COVID-19 |
Intermountain Health Care, Inc. |
2020-04-02 | PHASE3 |
| NCT04351516 | WITHDRAWN | SARS-CoV 2; COVID-19 |
University Hospital Tuebingen |
2020-04-21 | PHASE2; PHASE3 |
| NCT04365582 | WITHDRAWN | COVID |
Fondation Hôpital Saint-Joseph |
2020-05-07 | PHASE3 |
| NCT04394182 | SUSPENDED | Pneumonia, Viral; Cytokine Storm |
Fundacion GenesisCare |
2020-04-21 | |
| NCT04318015 | COMPLETED | COVID-19; Severe Acute Respiratory Syndrome |
National Institute of Respiratory Diseases, Mexico |
2020-04-14 | PHASE3 |
| NCT04411433 | UNKNOWN | Sars-CoV2; COVID-19 |
Ministry of Health, Turkey |
2020-05-08 | PHASE3 |
| NCT03122431 | COMPLETED | Systemic Lupus Erythematosus (SLE); Juvenile SLE; Cutaneous Lupus |
University of Sao Paulo General Hospital |
2017-06-05 | PHASE4 |
| NCT04347889 | WITHDRAWN | Covid-19 |
Stony Brook University |
2020-04-20 | PHASE2 |
| NCT03400865 | UNKNOWN | Resistance, Disease; Prolactinoma |
Zhebao Wu |
2018-10-25 | |
| NCT04331600 | COMPLETED | COVID-19 |
Wroclaw Medical University |
2020-04-16 | PHASE4 |
| NCT04334148 | COMPLETED | COVID-19 |
Adrian Hernandez |
2020-04-22 | PHASE3 |
| NCT04429867 | UNKNOWN | COVID-19 |
WellStar Health System |
2020-05-07 | PHASE4 |
| NCT04772846 | UNKNOWN | Glioblastoma |
Egyptian Medical Syndicate |
2018-03-01 | PHASE1; PHASE2 |
| NCT04405921 | UNKNOWN | SARS-CoV-2 Pneumonia; COVID-19 |
Centre Hôpital Universitaire Farhat Hached |
2020-07 | PHASE3 |
| NCT04344951 | TERMINATED | Pneumonia, Viral; Covid-19 |
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. |
2020-04-06 | PHASE2 |
| NCT04414241 | COMPLETED | SARS-CoV-2 |
Universidad Peruana Cayetano Heredia |
2020-06-25 | PHASE3 |
| NCT04338698 | COMPLETED | COVID 19 |
Shehnoor Azhar |
2020-04-22 | PHASE3 |
| NCT04788355 | COMPLETED | Complication |
Universidade do Vale do Sapucai |
2020-07-01 | PHASE3 |
| NCT04329923 | TERMINATED | COVID-19 |
Ravi Amaravadi, MD |
2020-04-09 | PHASE2 |
| NCT04330495 | WITHDRAWN | COVID 19; Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors |
Instituto de Investigación Marqués de Valdecilla |
2020-04-06 | PHASE4 |
| NCT04361461 | WITHDRAWN | Coronavirus Infections; SARS-CoV 2; SARS (Severe Acute Respiratory Syndrome); Pulmonary Disease |
Apsen Farmaceutica S.A. |
2020-04-30 | PHASE3 |
| NCT04354428 | TERMINATED | COVID-19; SARS-CoV-2 |
University of Washington |
2020-04-16 | PHASE2; PHASE3 |
| NCT04347031 | COMPLETED | Pneumonia, Viral; Respiratory Failure |
Burnasyan Federal Medical Biophysical Center |
2020-04-08 | PHASE2; PHASE3 |
| NCT04374552 | WITHDRAWN | SARS-CoV-2 Infection |
Rutgers, The State University of New Jersey |
2020-05-05 | PHASE2 |
| NCT04443270 | UNKNOWN | COVID-19 |
CMN "20 de Noviembre" |
2020-07-27 | PHASE1 |
| NCT04652648 | COMPLETED | Covid19; Hydroxychloroquine; Coronavirus Infection; Transmission; Prophylaxis |
Bryn Mawr Hospital |
2020-05-27 | PHASE4 |
| NCT04336332 | TERMINATED | SARS-CoV-2; COVID-19 |
Rutgers, The State University of New Jersey |
2020-04-01 | PHASE2 |
| NCT04340544 | TERMINATED | COVID-19 |
University Hospital Tuebingen |
2020-04-22 | PHASE2 |
| NCT04355052 | UNKNOWN | COVID - 19 |
Sheba Medical Center |
2020-04-11 | PHASE3 |
| NCT04443725 | UNKNOWN | COVID-19 |
Cairo University |
2020-07 | PHASE2; PHASE3 |
| NCT04361318 | UNKNOWN | COVID-19 |
Tanta University |
2020-05 | PHASE2; PHASE3 |
| NCT04370782 | COMPLETED | COVID-19 |
St. Francis Hospital, New York |
2020-04-28 | PHASE4 |
| NCT04351295 | COMPLETED | COVID |
Tanta University |
2020-04-20 | PHASE2; PHASE3 |
| NCT04379492 | WITHDRAWN | COVID-19; COVID19; Sars-CoV2; SARS-Cov-2 |
Memorial Sloan Kettering Cancer Center |
2020-05-05 | PHASE2 |
| NCT04328961 | COMPLETED | COVID-19; Corona Virus Infection; SARS (Severe Acute Respiratory Syndrome); SARS-CoV-2 |
University of Washington |
2020-03-31 | PHASE2; PHASE3 |
| NCT04466280 | WITHDRAWN | COVID-19 |
Baqiyatallah Medical Sciences University |
2020-08-12 | |
| NCT04354870 | COMPLETED | COVID-19 |
NYU Langone Health |
2020-04-03 | PHASE2 |
| NCT04349410 | COMPLETED | CoVid 19 Positive |
The Camelot Foundation |
2020-04-11 | PHASE2; PHASE3 |
| NCT04384458 | UNKNOWN | Coronavirus Infections |
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara |
2020-07-20 | |
| NCT04328493 | COMPLETED | SARS-CoV-2 Infection; COVID-19 |
Oxford University Clinical Research Unit, Vietnam |
2020-04-07 | PHASE2 |
| NCT04392128 | WITHDRAWN | COVID19; Hematologic Malignancy |
Institut de cancérologie Strasbourg Europe |
2020-09-02 | PHASE2 |
| NCT04575558 | WITHDRAWN | Sars-CoV2 |
Latin American Cooperative Oncology Group |
2020-06-30 | PHASE2 |
| NCT04333628 | TERMINATED | COVID-19 |
HaEmek Medical Center, Israel |
2020-06-01 | PHASE2; PHASE3 |
| NCT04446104 | COMPLETED | Covid-19 |
National University Hospital, Singapore |
2020-05-13 | PHASE3 |
| NCT04345692 | TERMINATED | COVID-19 |
Queen's Medical Center |
2020-03-26 | PHASE3 |
| NCT04341493 | TERMINATED | Coronavirus Infection |
Hugo Mendieta Zeron |
2020-04-06 | PHASE4 |
| NCT04501965 | UNKNOWN | Covid19 |
Institute for Research and Development of Medicinal and Food Plants of Guinea |
2020-06-01 | PHASE2 |
| NCT04383717 | UNKNOWN | Respiratory Tract Infections |
Cairo University |
2020-05-05 | PHASE3 |
| NCT04359537 | UNKNOWN | COVID 19 |
Shaheed Zulfiqar Ali Bhutto Medical University |
2020-05-01 | PHASE2 |
| NCT04346667 | TERMINATED | SARS-CoV-2; Coronavirus Infection; Asymptomatic Condition; COVID-19 |
Government of Punjab, Specialized Healthcare and Medical Education Department |
2020-04-14 | PHASE4 |
| NCT04351191 | TERMINATED | Sars-CoV2; Symptomatic Condition; Covid-19 |
Government of Punjab, Specialized Healthcare and Medical Education Department |
2020-04-15 | PHASE4 |
| NCT04420247 | COMPLETED | COVID; COVID-19; SARS-CoV 2; Coronavirus; Corona Virus Infection |
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva |
2020-04-16 | PHASE3 |
| NCT04354597 | WITHDRAWN | COVID-19 |
King Hussein Cancer Center |
2020-05-01 | |
| NCT04349592 | COMPLETED | Covid19 |
Hamad Medical Corporation |
2020-04-14 | |
| NCT04347980 | TERMINATED | Respiratory Distress Syndrome, Adult; COVID-19 |
Centre Chirurgical Marie Lannelongue |
2020-04-17 | PHASE3 |
| NCT02595346 | TERMINATED | Antiphospholipid Syndrome (APS) |
University Hospital, Rouen |
2016-05-17 | PHASE2 |
| NCT04350450 | WITHDRAWN | COVID; Coronavirus; COVID-19 |
Montefiore Medical Center |
2020-04 | PHASE2 |
| NCT04321616 | UNKNOWN | SARS-CoV Infection; COVID 19; Acute Respiratory Distress Syndrome ARDS |
Oslo University Hospital |
2020-03-28 | PHASE2; PHASE3 |
| NCT04371406 | WITHDRAWN | Covid-19 |
Assistance Publique - Hôpitaux de Paris |
2020-04 | PHASE3 |
| NCT05110651 | WITHDRAWN | COVID-19; End Stage Renal Disease |
Nicholas Carlson |
2020-04-10 | PHASE4 |
| NCT04329611 | TERMINATED | COVID-19 |
Dr. Michael Hill |
2020-04-13 | PHASE3 |
| NCT01379573 | COMPLETED | Congenital Heart Block; Neonatal Lupus; Autoantibody-Associated Heart Block |
NYU Langone Health |
2011-01-01 | PHASE2 |
| NCT04447534 | COMPLETED | COVID |
Tanta University |
2020-06-23 | PHASE3 |
| NCT04435808 | TERMINATED | COVID-19 |
University of New Mexico |
2020-04-14 | PHASE1; PHASE2 |
| NCT04349228 | WITHDRAWN | COVID19; Sars-CoV2; Hydroxychloroquine; Prophylaxis; Healthcare Worker |
Abderrahmane Mami Hospital |
2020-04-28 | PHASE3 |
| NCT04351919 | WITHDRAWN | Patients With COVID19 |
Abderrahmane Mami Hospital |
2020-05-05 | PHASE4 |
| NCT04328467 | COMPLETED | COVID-19; Corona Virus Infection; ARDS; Acute Respiratory Distress Syndrome |
University of Minnesota |
2020-04-06 | PHASE3 |
| NCT04627467 | COMPLETED | Covid19 |
Fundacion Clinica Valle del Lili |
2020-03-28 | PHASE2 |
| NCT04358068 | TERMINATED | COVID-19; SARS-CoV 2 |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-05-13 | PHASE2 |
| NCT04353271 | TERMINATED | Covid 19; Corona Virus Infection |
University of South Alabama |
2020-04-17 | PHASE2; PHASE3 |
| NCT04315896 | COMPLETED | COVID-19; Severe Acute Respiratory Syndrome |
National Institute of Respiratory Diseases, Mexico |
2020-04-14 | PHASE3 |
| NCT04329832 | COMPLETED | COVID-19 |
Intermountain Health Care, Inc. |
2020-03-30 | PHASE2 |
| NCT04350281 | COMPLETED | COVID |
The University of Hong Kong |
2020-04-09 | PHASE2 |
| NCT04333225 | COMPLETED | COVID-19 |
Baylor Research Institute |
2020-04-03 | PHASE2 |
| NCT04355026 | UNKNOWN | Covid-19 |
General and Teaching Hospital Celje |
2020-04-10 | PHASE4 |
| NCT04370015 | UNKNOWN | SARS-CoV-2; Healthcare Workers |
Services Institute of Medical Sciences, Pakistan |
2020-05-15 | |
| NCT04348474 | SUSPENDED | Covid-19 |
Azidus Brasil |
2020-04-20 | EARLY_PHASE1 |
| NCT04346329 | WITHDRAWN | COVID |
Universidad Nacional de Colombia |
2020-03-30 | PHASE3 |
| NCT04161339 | UNKNOWN | Cardiovascular Diseases; Endothelial Dysfunction; Sleep Apnea; Atherosclerosis; Coronary Artery Disease |
Instituto de Cardiologia do Rio Grande do Sul |
2019-07-01 | PHASE4 |
| NCT04330144 | WITHDRAWN | Contact Person From COVID-19 Confirmed Patient |
Gangnam Severance Hospital |
2020-04-01 | PHASE3 |
| NCT04331834 | COMPLETED | COVID-19 |
Barcelona Institute for Global Health |
2020-04-03 | PHASE3 |
| NCT04344457 | UNKNOWN | COVID-19 |
Perseverance Research Center, LLC |
2020-04-16 | PHASE1; PHASE2 |
| NCT04332991 | COMPLETED | Coronavirus; Acute Respiratory Infection; SARS-CoV Infection |
Massachusetts General Hospital |
2020-04-02 | PHASE3 |
| NCT04325893 | TERMINATED | Coronavirus |
University Hospital, Angers |
2020-04-01 | PHASE3 |
| NCT04344379 | COMPLETED | SARS-CoV-2 Infection |
Assistance Publique - Hôpitaux de Paris |
2020-04-17 | PHASE3 |
| NCT04335552 | TERMINATED | SARS-CoV-2 |
Duke University |
2020-04-17 | PHASE2 |
| NCT04321278 | COMPLETED | Coronavirus Infections; Pneumonia, Viral |
Hospital Israelita Albert Einstein |
2020-03-28 | PHASE3 |
| NCT04362332 | TERMINATED | COVID-19 |
UMC Utrecht |
2020-04-14 | PHASE4 |
| NCT04322123 | COMPLETED | Coronavirus Infections |
Hospital do Coracao |
2020-04-01 | PHASE3 |
| NCT04347512 | WITHDRAWN | Sars-CoV-2, Community-Acquired Pneumonia,COVID-19 |
University Hospital, Strasbourg, France |
2020-06-02 | PHASE3 |
| NCT03215264 | COMPLETED | Colorectal Cancer |
Abramson Cancer Center at Penn Medicine |
2017-10-02 | PHASE1 |
| NCT04365231 | WITHDRAWN | COVID19 |
Hospital St. Joseph, Marseille, France |
2020-04-01 | PHASE3 |
| NCT04353336 | COMPLETED | COVID-19; Coronavirus Infection |
Tanta University |
2020-03-23 | PHASE2; PHASE3 |
| NCT03283566 | COMPLETED | Chronic Pancreatitis; Insulin Dependent Diabetes |
The Cleveland Clinic |
2017-10-03 | PHASE2 |
| NCT04329572 | SUSPENDED | COVID-19 |
Azidus Brasil |
2020-04-23 | EARLY_PHASE1 |
| NCT04328272 | UNKNOWN | COVID19 |
Prof. Dr. Umar Farooq |
2020-03-28 | PHASE3 |
| NCT04522466 | TERMINATED | Sars-CoV2 |
Centre Hospitalier Universitaire de Saint Etienne |
2020-04-03 | PHASE3 |
| NCT04333654 | TERMINATED | Coronavirus Infection |
Sanofi |
2020-04-12 | PHASE1 |
| NCT04316377 | UNKNOWN | Corona Virus Infection |
University Hospital, Akershus |
2020-03-25 | PHASE4 |
| NCT04377646 | UNKNOWN | Sars-CoV2; COVID19 |
Military Hospital of Tunis |
2020-05-04 | PHASE3 |
| NCT04308668 | COMPLETED | Corona Virus Infection; Acute Respiratory Distress Syndrome; SARS-CoV Infection; Coronavirus; Coronavirus Infections |
University of Minnesota |
2020-03-17 | PHASE3 |
| NCT04342650 | COMPLETED | COVID-19; SARS-CoV Infection; Severe Acute Respiratory Syndrome (SARS) Pneumonia; Clinical Trial |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2020-04-08 | PHASE2 |
| NCT04328285 | TERMINATED | COVID-19 |
Centre Hospitalier Universitaire de Saint Etienne |
2020-04-14 | PHASE3 |
| NCT04341870 | SUSPENDED | COVID19; SARS-CoV-2 Infection |
Assistance Publique - Hôpitaux de Paris |
2020-04-11 | PHASE2; PHASE3 |
| NCT04323527 | COMPLETED | SARS-CoV Infection; Severe Acute Respiratory Syndrome (SARS) Pneumonia |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2020-03-23 | PHASE2 |
| NCT03856866 | COMPLETED | Zellweger Syndrome; Peroxisome Biogenesis Disorders |
The Hospital for Sick Children |
2019-01-11 | PHASE2 |
| NCT04359316 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-20 | PHASE4 |
| NCT04359615 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-20 | PHASE4 |
| NCT04354441 | WITHDRAWN | COVID-19; SARS-CoV-2; Pregnant Women; Hydroxychloroquine |
Sir Mortimer B. Davis - Jewish General Hospital |
2020-05 | PHASE2 |
| NCT04323631 | WITHDRAWN | COVID-19 |
Rambam Health Care Campus |
2020-04-30 | EARLY_PHASE1 |
| NCT04307693 | TERMINATED | COVID-19 |
Asan Medical Center |
2020-03-11 | PHASE2 |
| NCT04343768 | COMPLETED | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-09 | PHASE2 |
| NCT04350684 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-15 | PHASE4 |
| NCT04331470 | UNKNOWN | COVID-19 |
Fasa University of Medical Sciences |
2020-04-04 | PHASE2; PHASE3 |
| NCT04350671 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-15 | PHASE4 |
| NCT04376814 | COMPLETED | COVID-19; Favipiravir; Kaletra; Hydroxychloroquine; Lopinavir/Ritonavir |
Baqiyatallah Medical Sciences University |
2020-03-29 | |
| NCT02932007 | RECRUITING | Atrial Fibrillation |
University of South Florida |
2017-03-28 | PHASE2 |
| NCT04261517 | COMPLETED | Pneumonia, Pneumocystis; Coronavirus; COVID-19 |
Shanghai Public Health Clinical Center |
2020-02-06 | PHASE3 |
| NCT01480154 | ACTIVE_NOT_RECRUITING | Advanced Malignant Solid Neoplasm; Stage III Cutaneous Melanoma AJCC v7; Stage III Prostate Cancer AJCC v7; Stage III Renal Cell Cancer AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Prostate Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7 |
National Cancer Institute (NCI) |
2011-11-23 | PHASE1 |
| NCT02648464 | COMPLETED | Myocardial Infarction; Acute Coronary Syndrome; Inflammation; Hydroxychloroquine; Antirheumatic Agents; Cardiovascular Diseases |
Helsinki University Central Hospital |
2016-02-01 | PHASE4 |
| NCT03592823 | UNKNOWN | Atrial Fibrillation |
First Affiliated Hospital of Harbin Medical University |
2018-08-01 | PHASE4 |
| NCT02563496 | COMPLETED | Malaria, Vivax |
GlaxoSmithKline |
2017-02-06 | PHASE2 |
| NCT02496741 | COMPLETED | Glioma; Cholangiocarcinoma; Chondrosarcoma |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2015-11 | PHASE1; PHASE2 |
| NCT04005768 | UNKNOWN | Obesity |
Universitaire Ziekenhuizen KU Leuven |
2019-08-01 | PHASE4 |
| NCT04153201 | COMPLETED | Antiphospholipid Syndrome |
National and Kapodistrian University of Athens |
2013-01-15 | |
| NCT03400254 | WITHDRAWN | Breast Cancer |
Abramson Cancer Center at Penn Medicine |
2019-02-26 | PHASE1; PHASE2 |
| NCT03081702 | COMPLETED | Platinum-resistant Epithelial Ovarian Cancer |
University Health Network, Toronto |
2017-07-25 | PHASE1; PHASE2 |
| NCT04022421 | UNKNOWN | Behcet's Syndrome, Vascular Type |
Assiut University |
2018-10-01 | |
| NCT03449758 | COMPLETED | Rheumatoid Arthritis |
Sanofi |
2018-03-05 | PHASE4 |
| NCT01946880 | TERMINATED | Systemic Lupus Erythematosus; SLE |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-11-20 | PHASE2 |
| NCT02379650 | WITHDRAWN | Recurrent Pregnancy Loss; Miscarriage |
University of Utah |
2016-07 | PHASE2 |
| NCT03275870 | COMPLETED | Hidradenitis Suppurativa; Hidradenitis; Acne Inversa; Boils; Follicular Occlusion Triad; Follicular Occlusion Tetrad |
Elena Gonzalez Brant, MD |
2017-09-28 | PHASE1; PHASE2 |
| NCT02615938 | TERMINATED | Interstitial Lung Disease; Diffuse Parenchymal Lung Disease; Children´s Interstitial Lung Disease |
Matthias Griese |
2015-08-21 | PHASE2 |
| NCT03083847 | COMPLETED | Malaria |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-06-05 | PHASE1 |
| NCT03344172 | TERMINATED | Pancreatic Cancer Resectable |
Nathan Bahary, MD |
2017-12-13 | PHASE2 |
| NCT01783106 | COMPLETED | Crohn's Disease |
Royal Liverpool University Hospital |
2014-02-01 | PHASE2 |
| NCT03610399 | COMPLETED | P Vivax; Malaria, Vivax |
Centers for Disease Control and Prevention |
2018-04-09 | |
| NCT02874287 | COMPLETED | Coronary Artery Disease |
First Affiliated Hospital Xi'an Jiaotong University |
2017-10-08 | PHASE4 |
| NCT01446016 | COMPLETED | Breast Neoplasms; Breast Cancer |
The Methodist Hospital Research Institute |
2011-09 | PHASE2 |
| NCT02378532 | COMPLETED | Glioblastoma Multiforme |
Maastricht Radiation Oncology |
2016-08 | PHASE1 |
| NCT02444728 | TERMINATED | Thrombocytopenia |
Chinese SLE Treatment And Research Group |
2015-07 | PHASE3 |
| NCT02876549 | COMPLETED | Vivax Malaria |
University of Oxford |
2016-09-01 | PHASE4 |
| NCT01494155 | COMPLETED | Pancreatic Cancer |
Massachusetts General Hospital |
2011-12-27 | PHASE2 |
| NCT03337152 | TERMINATED | Malaria, Vivax; G6PD Deficiency |
PATH |
2018-05-07 | PHASE4 |
| NCT02910076 | UNKNOWN | Diabetes Type Two |
Hadassah Medical Organization |
2016-10 | PHASE1; PHASE2 |
| NCT02564471 | COMPLETED | Rabies |
State University of New York - Upstate Medical University |
2016-11-11 | PHASE4 |
| NCT01650558 | COMPLETED | HIV |
University of Maryland, Baltimore |
2012-11 | |
| NCT02996695 | COMPLETED | Plasmodium Falciparum Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-04-06 | PHASE1 |
| NCT03229746 | COMPLETED | Immune Thrombocytopenia |
Assiut University |
2017-08-01 | PHASE4 |
| NCT02316340 | COMPLETED | Colorectal Cancer |
The University of Texas Health Science Center at San Antonio |
2015-02-11 | PHASE2 |
| NCT01550367 | COMPLETED | Metastatic Renal Cell Carcinoma |
Leonard Appleman |
2012-03 | PHASE1; PHASE2 |
| NCT01978184 | COMPLETED | Pancreatic Cancer |
Nathan Bahary, MD |
2013-11 | PHASE2 |
| NCT02773979 | COMPLETED | Plasmodium Falciparum Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-09-12 | PHASE1 |
| NCT02942381 | COMPLETED | IgA Patients; Hydroxychloroquine |
Peking University First Hospital |
2016-09-13 | PHASE2 |
| NCT02232243 | COMPLETED | Solid Tumor |
Peng Wang, MD PhD |
2015-07 | PHASE1 |
| NCT01023737 | COMPLETED | Malignant Solid Tumour |
The University of Texas Health Science Center at San Antonio |
2009-11 | PHASE1 |
| NCT02859350 | COMPLETED | Malaria |
Sanaria Inc. |
2016-11 | PHASE1 |
| NCT02348788 | UNKNOWN | Plasmodium Vivax Malaria Without Complication |
Menzies School of Health Research |
2015-01 | PHASE3 |
| NCT02303405 | TERMINATED | Diabetes Mellitus Type 2 With Hyperglycemia |
Charles Drew University of Medicine and Science |
2014-11 | PHASE2 |
| NCT01206530 | COMPLETED | Rectal Cancer; Colon Cancer; Metastasis; Adenocarcinoma |
Abramson Cancer Center at Penn Medicine |
2010-09 | PHASE1; PHASE2 |
| NCT02451748 | COMPLETED | Rheumatoid Arthritis |
University of Illinois at Chicago |
2015-08 | PHASE4 |
| NCT02433184 | COMPLETED | Rheumatoid Arthritis |
University of Leeds |
2011-07 | PHASE4 |
| NCT01575782 | TERMINATED | Small Cell Lung Cancer |
Maastricht Radiation Oncology |
2014-05 | PHASE1 |
| NCT02333890 | UNKNOWN | Breast Cancer; Invasive Breast Cancer |
Ottawa Hospital Research Institute |
2015-07 | PHASE2 |
| NCT02644499 | COMPLETED | Rheumatoid Arthritis |
Jawaharlal Institute of Postgraduate Medical Education & Research |
2015-12-31 | PHASE4 |
| NCT02216123 | COMPLETED | Malaria, Vivax |
GlaxoSmithKline |
2015-04-30 | PHASE3 |
| NCT01546961 | COMPLETED | Vivax Malaria |
University of Oxford |
2011-06 | |
| NCT02511054 | COMPLETED | Malaria |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-07-21 | PHASE1 |
| NCT02610686 | UNKNOWN | Plasmodium Vivax |
National Institute of Malariology, Parasitology and Entomology, Vietnam |
2015-03 | PHASE4 |
| NCT01023477 | COMPLETED | Carcinoma, Intraductal, Noninfiltrating; DCIS; Ductal Carcinoma In Situ |
Inova Health Care Services |
2009-12 | PHASE1; PHASE2 |
| NCT01144169 | TERMINATED | Renal Cell Carcinoma |
University of Pittsburgh |
2010-10 | PHASE1 |
| NCT01718054 | UNKNOWN | Sickle Cell Disease |
London School of Hygiene and Tropical Medicine |
2012-08 | PHASE2; PHASE3 |
| NCT02124681 | COMPLETED | Insulin Resistance |
University of Pittsburgh |
2014-04 | PHASE1 |
| NCT01897116 | COMPLETED | Melanoma |
Abramson Cancer Center at Penn Medicine |
2013-06 | PHASE1 |
| NCT01941095 | COMPLETED | Rheumatoid Arthritis |
Hoffmann-La Roche |
2013-11-20 | PHASE3 |
| NCT00969306 | TERMINATED | Small Cell Lung Cancer |
Maastricht Radiation Oncology |
2013-09 | PHASE1 |
| NCT01645176 | COMPLETED | Osteoarthritis of the Knee |
Stanford University |
2012-05 | PHASE2 |
| NCT02421575 | TERMINATED | Prostate Carcinoma |
Rutgers, The State University of New Jersey |
2012-07 | EARLY_PHASE1 |
| NCT01828476 | TERMINATED | Prostate Cancer |
Rutgers, The State University of New Jersey |
2013-06 | PHASE2 |
| NCT02126683 | UNKNOWN | Hashimoto's Thyroiditis |
National Taiwan University Hospital |
2014-04 | |
| NCT01634893 | COMPLETED | Refractory or Relapsed Solid Tumors |
The University of Texas Health Science Center at San Antonio |
2012-06 | PHASE1 |
| NCT02079077 | COMPLETED | HIV |
University of Manitoba |
2014-04 | |
| NCT02475915 | COMPLETED | Acute HIV Infection |
SEARCH Research Foundation |
2015-01 | PHASE1; PHASE2 |
| NCT02351752 | COMPLETED | Primary IgA Nephropathy |
LLiu |
2015-01 | PHASE4 |
| NCT01784523 | TERMINATED | Antiphospholipid Syndrome |
Hospital for Special Surgery, New York |
2013-02 | PHASE3 |
| NCT02756546 | COMPLETED | Systemic Lupus Erythematosis |
Cairo University |
2014-09 | PHASE1; PHASE2 |
| NCT02192944 | COMPLETED | Healthy |
University of Oxford |
2014-07 | PHASE4 |
| NCT01006369 | COMPLETED | Colorectal Cancer |
Rutgers, The State University of New Jersey |
2009-05 | PHASE2 |
| NCT02691910 | COMPLETED | Malaria, Vivax |
Oswaldo Cruz Foundation |
2014-08 | PHASE2; PHASE3 |
| NCT01687179 | COMPLETED | Lymphangioleiomyomatosis |
Brigham and Women's Hospital |
2012-09 | PHASE1 |
| NCT01469455 | COMPLETED | Local Metastatic Melanoma |
DNA Therapeutics |
2011-10 | PHASE1 |
| NCT01640574 | COMPLETED | Vivax Malaria |
University of Oxford |
2012-02 | PHASE3 |
| NCT02080026 | COMPLETED | Malaria |
Radboud University Medical Center |
2014-06 | |
| NCT01649947 | COMPLETED | Non-small Cell Lung Cancer; Advanced Non-small Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer |
Rutgers, The State University of New Jersey |
2011-12-23 | PHASE2 |
| NCT02463331 | COMPLETED | Autoimmune Hepatitis |
University of Sao Paulo General Hospital |
2003-05 | PHASE4 |
| NCT00977470 | ACTIVE_NOT_RECRUITING | Non-small Cell Lung Cancer |
Massachusetts General Hospital |
2009-10 | PHASE2 |
| NCT01495403 | COMPLETED | Liver Cirrhosis; Muscle Cramps |
Mayo Clinic |
2011-12 | EARLY_PHASE1 |
| NCT02698748 | COMPLETED | Malaria |
Centro de Investigacao em Saude de Manhica |
2015-01 | PHASE2; PHASE3 |
| NCT02057250 | COMPLETED | RA |
Sanofi |
2014-03 | PHASE3 |
| NCT02001012 | COMPLETED | Uncomplicated Knowlesi Malaria |
Menzies School of Health Research |
2014-01 | PHASE3 |
| NCT01842594 | TERMINATED | Sarcoma |
Shin Kong Wu Ho-Su Memorial Hospital |
2012-08 | PHASE2 |
| NCT01662700 | UNKNOWN | Acute Uncomplicated Malaria With P.Vivax Infection |
Mahidol University |
2012-10 | PHASE4 |
| NCT02118090 | COMPLETED | Vivax Malaria |
Institut Pasteur, Cambodia |
2014-05 | PHASE4 |
| NCT01708876 | COMPLETED | Uncomplicated Plasmodium Knowlesi Malaria |
Menzies School of Health Research |
2012-10 | PHASE3 |
| NCT02043652 | COMPLETED | Malaria |
Centers for Disease Control and Prevention |
2014-02 | |
| NCT01768572 | COMPLETED | Rheumatoid Arthritis |
Sanofi |
2013-03 | PHASE3 |
| NCT01443130 | COMPLETED | Malaria |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-02 | PHASE3 |
| NCT01232660 | UNKNOWN | HIV Infection |
St Stephens Aids Trust |
2010-10 | PHASE1 |
| NCT02058173 | COMPLETED | Hepatitis C Virus |
Shiraz University of Medical Sciences |
2014-01 | PHASE4 |
| NCT01833845 | TERMINATED | Hepatitis C |
BioLineRx, Ltd. |
2013-04 | PHASE1; PHASE2 |
| NCT01438177 | TERMINATED | Multiple Myeloma |
NYU Langone Health |
2011-10 | PHASE2 |
| NCT01178021 | COMPLETED | Vivax Malaria |
University of Oxford |
2009-08 | PHASE4 |
| NCT00726596 | COMPLETED | Prostate Cancer |
Rutgers, The State University of New Jersey |
2008-08 | PHASE2 |
| NCT01728701 | COMPLETED | Malaria; Plasmodium Falciparum |
Sanaria Inc. |
2012-09 | PHASE1 |
| NCT01783340 | WITHDRAWN | Malaria, Falciparum |
Radboud University Medical Center |
2013-04 | PHASE1; PHASE2 |
| NCT01103063 | TERMINATED | Intermittent Preventive Treatment In Pregnancy (IPTp) |
Pfizer |
2010-10 | PHASE3 |
| NCT01207739 | COMPLETED | Lyme Disease; Borrelia Infection |
Radboud University Medical Center |
2010-09 | PHASE4 |
| NCT01537315 | TERMINATED | Kidney Failure, Chronic; Cardiovascular Disease; Arteriosclerosis |
University of Arkansas |
2012-02 | PHASE2 |
| NCT01727531 | COMPLETED | Brain Metastasis |
Main Line Health |
2008-12 | |
| NCT01601028 | COMPLETED | Autoimmune Diseases; Sjogren's Syndrome; Dry Eye |
Seoul National University Hospital |
2011-07 | PHASE3 |
| NCT02200146 | COMPLETED | Pulmonary Sarcoidosis |
University of Milano Bicocca |
2009-03 | PHASE3 |
| NCT01103713 | TERMINATED | Asymptomatic Parasitemia In Pregnancy |
Pfizer |
2011-03 | PHASE3 |
| NCT01378286 | COMPLETED | Malaria |
Sanofi |
2012-01 | PHASE3 |
| NCT00486603 | COMPLETED | Brain and Central Nervous System Tumors |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2007-10-29 | PHASE1; PHASE2 |
| NCT00962845 | COMPLETED | Melanoma (Skin) |
Rutgers, The State University of New Jersey |
2010-09 | EARLY_PHASE1 |
| NCT01205178 | COMPLETED | Malaria |
GlaxoSmithKline |
2009-07-02 | PHASE1 |
| NCT01326533 | COMPLETED | Pre-diabetes |
University of Pittsburgh |
2011-03 | PHASE4 |
| NCT00819390 | COMPLETED | HIV Infections |
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
2009-03 | PHASE2 |
| NCT01273805 | COMPLETED | Pancreatic Cancer |
Dana-Farber Cancer Institute |
2011-01 | PHASE2 |
| NCT01760421 | COMPLETED | Hashimoto Thyroiditis |
National Taiwan University Hospital |
2011-10 | |
| NCT01040195 | COMPLETED | Seronegative Spondyloarthropathies |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2009-06 | PHASE3 |
| NCT01026844 | TERMINATED | Non-small Cell Lung Cancer |
Massachusetts General Hospital |
2007-07 | PHASE1 |
| NCT00786682 | TERMINATED | Prostate Cancer |
University of Medicine and Dentistry of New Jersey |
2008-12 | PHASE2 |
| NCT01396200 | COMPLETED | Myeloma |
Abramson Cancer Center at Penn Medicine |
2011-06 | EARLY_PHASE1 |
| NCT01074905 | COMPLETED | Vivax Malaria |
University of Oxford |
2010-05 | PHASE3 |
| NCT01500980 | COMPLETED | Malaria |
Seattle Children's Hospital |
2011-12 | PHASE1 |
| NCT01236612 | COMPLETED | Plasmodium Falciparum Malaria |
Radboud University Medical Center |
2011-04 | |
| NCT00909831 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Abramson Cancer Center at Penn Medicine |
2008-10 | PHASE1 |
| NCT01132118 | COMPLETED | Rheumatoid Arthritis; Insulin Resistance |
Brigham and Women's Hospital |
2010-06 | PHASE3 |
| NCT01227135 | UNKNOWN | Leukemia |
Lynn McMahon |
2010-03 | PHASE2 |
| NCT01107145 | TERMINATED | Plasmodium Vivax Malaria |
Centers for Disease Control and Prevention |
2011-02 | PHASE4 |
| NCT01272310 | UNKNOWN | Chronic Hepatitis C |
Sheba Medical Center |
2011-01 | PHASE1; PHASE2 |
| NCT00771056 | TERMINATED | B-Cell Chronic Lymphocytic Leukemia |
Northwell Health |
2008-07 | PHASE2 |
| NCT01292408 | UNKNOWN | Breast Cancer |
Radboud University Medical Center |
2011-01 | PHASE2 |
| NCT02004314 | COMPLETED | HIV |
CIHR Canadian HIV Trials Network |
2009-10 | |
| NCT00765765 | TERMINATED | Breast Cancer |
University of Medicine and Dentistry of New Jersey |
2009-02 | PHASE1; PHASE2 |
| NCT00405275 | COMPLETED | Rheumatoid Arthritis |
US Department of Veterans Affairs |
2007-07 | |
| NCT01218932 | COMPLETED | Vivax Malaria |
University of Oxford |
2010-10 | PHASE1 |
| NCT01366235 | COMPLETED | Healthy Volunteers |
Asan Medical Center |
2011-05 | PHASE1 |
| NCT00714181 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Abramson Cancer Center at Penn Medicine |
2008-06 | PHASE1 |
| NCT00632866 | COMPLETED | Primary Sjögren's Syndrome |
Assistance Publique - Hôpitaux de Paris |
2008-03 | PHASE3 |
| NCT01067417 | UNKNOWN | HIV Infections |
Medical Research Council |
2008-06 | PHASE2 |
| NCT00728845 | TERMINATED | Lung Cancer |
University of Medicine and Dentistry of New Jersey |
2008-06-16 | PHASE1; PHASE2 |
| NCT04368910 | TERMINATED | Malaria |
Medicines for Malaria Venture |
2007-09-06 | PHASE3 |
| NCT00972725 | COMPLETED | AIDS |
GlaxoSmithKline |
2009-12-01 | PHASE2 |
| NCT02394197 | COMPLETED | Malaria |
LILIA GONZALEZ CERON |
2008-02 | PHASE4 |
| NCT00677833 | COMPLETED | Malaria, Falciparum |
Pfizer |
2008-06 | PHASE2; PHASE3 |
| NCT00964691 | TERMINATED | Malaria; Malaria in Pregnancy |
Ministry of Health and Medical Services, Solomon Islands |
2009-08 | PHASE4 |
| NCT01100060 | COMPLETED | Malaria Prophylaxis |
Pfizer |
2010-04 | PHASE1 |
| NCT01078779 | UNKNOWN | Influenza |
National University Hospital, Singapore |
2009-11 | PHASE2 |
| NCT02143934 | COMPLETED | Plasmodium Vivax Infection; Plasmodium Vivax Clinical Episode; Plasmodium Falciparum Infection; Plasmodium Falciparum Clinical Episode |
Papua New Guinea Institute of Medical Research |
2009-08 | PHASE4 |
| NCT00805519 | COMPLETED | Osteoarthritis of the Knee |
Ardabil University of Medical Sciences |
2009-02 | PHASE4 |
| NCT00579878 | COMPLETED | Rheumatoid Arthritis |
University of Nebraska |
2001-03-27 | PHASE3 |
| NCT00682578 | COMPLETED | Uncomplicated Falciparum Malaria; Vivax Malaria |
University of Oxford |
2007-07 | PHASE3 |
| NCT01052584 | COMPLETED | Malaria |
Centers for Disease Control and Prevention |
2009-10 | |
| NCT00455403 | COMPLETED | Metabolic Syndrome X; Overweight; Hypertension; Dyslipidemias; Prediabetic State |
Washington University School of Medicine |
2006-04 | |
| NCT00871156 | COMPLETED | Malaria |
GlaxoSmithKline |
2009-03-24 | PHASE1 |
| NCT00379821 | COMPLETED | Plasmodium Falciparum Infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-02 | PHASE3 |
| NCT00164255 | COMPLETED | Malaria |
Centers for Disease Control and Prevention |
2003-01 | PHASE4 |
| NCT00259610 | COMPLETED | Rheumatoid Arthritis |
University of Alabama at Birmingham |
2004-05 | PHASE4 |
| NCT00844207 | COMPLETED | Malaria |
Pfizer |
2009-02 | PHASE1 |
| NCT00473837 | COMPLETED | Malaria Anaemia |
Medical Research Council Unit, The Gambia |
2007-07 | |
| NCT00811096 | COMPLETED | Malaria, Vivax |
Walter Reed Army Institute of Research (WRAIR) |
2008-11 | PHASE2 |
| NCT00308620 | TERMINATED | HIV Infections |
University of Minnesota |
2006-03 | PHASE2; PHASE3 |
| NCT00426439 | COMPLETED | Malaria, Falciparum |
Bandim Health Project |
2006-12 | PHASE4 |
| NCT00229775 | COMPLETED | Malaria |
Centers for Disease Control and Prevention |
2003-07 | |
| NCT00849602 | UNKNOWN | Dengue |
University of Sao Paulo |
2008-02 | PHASE1; PHASE2 |
| NCT00440999 | COMPLETED | Malaria |
Medicines for Malaria Venture |
2007-03 | PHASE3 |
| NCT00521924 | TERMINATED | Rheumatoid Arthritis |
Merck Sharp & Dohme LLC |
2007-06 | PHASE3 |
| NCT00282919 | COMPLETED | Falciparum Malaria |
Pfizer |
2006-03 | PHASE2 |
| NCT00290420 | WITHDRAWN | Malaria |
Institut de Recherche pour le Developpement |
2006-03 | PHASE4 |
| NCT00367653 | COMPLETED | Malaria |
Pfizer |
2006-11 | PHASE3 |
| NCT00140517 | COMPLETED | Malaria in Pregnancy; Birth Weight; Anaemia |
London School of Hygiene and Tropical Medicine |
2002-10 | |
| NCT00399074 | COMPLETED | Sickle Cell Anemia; Malaria |
Makerere University |
2006-10 | PHASE3 |
| NCT00680732 | COMPLETED | Malaria; Malaria in Pregnancy |
Institute of Tropical Medicine, Belgium |
2003-06 | PHASE4 |
| NCT00730366 | COMPLETED | Malaria in Pregnancy |
Institute of Tropical Medicine, Belgium |
2004-03 | PHASE3 |
| NCT00259142 | TERMINATED | Fever; Anaemia; Malaria |
DBL -Institute for Health Research and Development |
2005-11 | |
| NCT00959517 | COMPLETED | Uncomplicated Falciparum Malaria |
London School of Hygiene and Tropical Medicine |
2001-07 | PHASE2 |
| NCT00031824 | COMPLETED | Graft Versus Host Disease |
Children's Oncology Group |
2002-04 | PHASE3 |
| NCT01290601 | TERMINATED | Malaria; Plasmodium Vivax |
U.S. Army Medical Research and Development Command |
2003-09-15 | PHASE2 |
| NCT00430807 | COMPLETED | Giant Cell Arteritis |
University Hospital, Toulouse |
2002-01 | PHASE3 |
| NCT00137514 | COMPLETED | Malaria, Falciparum |
Bandim Health Project |
2001-03 | PHASE4 |
| NCT01019408 | COMPLETED | Malaria, Falciparum |
London School of Hygiene and Tropical Medicine |
1993-11 | PHASE4 |
| NCT00946790 | COMPLETED | Immunosuppression; Rheumatism |
Sandoz |
1993-07 | PHASE1 |
| NCT00442377 | COMPLETED | Falciparum Malaria |
Radboud University Medical Center |
2007-01 | |
| NCT00224978 | COMPLETED | Glioblastoma Multiforme |
National Institute of Neurology and Neurosurgery, Mexico |
2005-01 | PHASE3 |
| NCT00391313 | TERMINATED | Chikungunya Virus |
Assistance Publique Hopitaux De Marseille |
2006-05 | PHASE3 |
| NCT00082563 | TERMINATED | Malaria, Falciparum |
Pfizer |
2004-08 | PHASE2 |
| NCT00132535 | COMPLETED | Malaria in Pregnancy; HIV Infections |
London School of Hygiene and Tropical Medicine |
2003-08 | |
| NCT00084240 | TERMINATED | Malaria, Falciparum |
Pfizer |
2004-03 | PHASE2; PHASE3 |
| NCT00158548 | COMPLETED | Malaria; Falciparum Malaria; Vivax Malaria |
London School of Hygiene and Tropical Medicine |
2001-06 | PHASE3 |
| NCT00131703 | COMPLETED | Malaria; Pregnancy |
London School of Hygiene and Tropical Medicine |
2003-03 | PHASE3 |
| NCT00074841 | COMPLETED | PLASMODIUM FALCIPARUM MALARIA |
Pfizer |
2003-09 | PHASE2; PHASE3 |
| NCT00084227 | COMPLETED | Malaria, Falciparum |
Pfizer |
2004-07 | PHASE2; PHASE3 |
| NCT00486694 | COMPLETED | Malaria, Vivax |
London School of Hygiene and Tropical Medicine |
2004-03 | PHASE2 |
| NCT00125489 | COMPLETED | Malaria; Plasmodium Falciparum Malaria |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-05 | PHASE4 |
(data from https://clinicaltrials.gov, updated on 2025-09-23)
Check the
Chloroquine
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Note: Technical data last updated: Sep 1, 2026.